Short Interest in Merck KGaA (OTCMKTS:MKKGY) Declines By 34.8%

Merck KGaA (OTCMKTS:MKKGY) saw a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 120,341 shares, a decline of 34.8% from the January 15th total of 184,605 shares. Based on an average daily volume of 138,732 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 138,732 shares, the days-to-cover ratio is presently 0.9 days.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft lowered Merck KGaA from a “buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Merck KGaA Stock Performance

OTCMKTS:MKKGY opened at $29.83 on Friday. The stock has a market cap of $19.28 billion, a P/E ratio of 11.88, a PEG ratio of 6.06 and a beta of 0.96. The company has a quick ratio of 0.97, a current ratio of 1.49 and a debt-to-equity ratio of 0.36. The business’s 50-day moving average price is $29.14 and its two-hundred day moving average price is $27.19. Merck KGaA has a twelve month low of $24.32 and a twelve month high of $31.00.

Merck KGaA (OTCMKTS:MKKGY) last posted its quarterly earnings data on Thursday, November 13th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.27. The company had revenue of $6.17 billion for the quarter, compared to analysts’ expectations of $6.08 billion. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. As a group, equities analysts predict that Merck KGaA will post 1.87 EPS for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.